Clinical Scorecard: Coronary CT Angiography Enhances Evaluation of Patients Experiencing Acute Chest Pain with Ambiguous High-Sensitivity Troponin Levels
At a Glance
Category
Detail
Condition
Acute chest pain with inconclusive high-sensitivity troponin levels suggestive of possible non-ST-segment elevation acute coronary syndrome (NSTE-ACS)
Key Mechanisms
Use of coronary computed tomography angiography (CCTA) to non-invasively detect obstructive coronary artery disease (≥ 50% stenosis) and other prognostic cardiac/non-cardiac findings
Target Population
Patients aged 30–80 years presenting to the emergency department with acute chest pain suspected of NSTE-ACS and inconclusively elevated hs-troponins who do not meet rule-in or rule-out criteria
Care Setting
Emergency department and outpatient clinic settings in hospital environments
Key Highlights
20–30% of patients with acute chest pain and hs-troponin testing fall into an inconclusive diagnostic category with heterogeneous prognosis
CCTA serves as a non-invasive gatekeeper to invasive coronary angiography, potentially reducing unnecessary invasive procedures
CCTA findings are classified by severity and prognostic importance, with significant CAD defined as ≥ 50% stenosis
Guideline-Based Recommendations
Diagnosis
Use clinical examination, ECG, and hs-troponin 0-h/1-h algorithms for initial evaluation
Identify patients with inconclusive hs-troponin results who require further evaluation
Perform CCTA within 1 week of presentation to assess coronary artery stenosis and other cardiac/non-cardiac findings
Management
Administer oral or intravenous metoprolol and sublingual nitroglycerin prior to CCTA unless contraindicated
Unblind and communicate CCTA results to treating clinicians and patients only if findings have important prognostic or management implications
Use CCTA findings to guide decisions on need for invasive coronary angiography
Monitoring & Follow-up
Systematic reading of CCTA scans by experienced cardiovascular radiologists using CAD-RADS classification
Monitor for significant coronary, cardiac, or non-cardiac findings that warrant further management or follow-up
Risks
Consider contraindications to CCTA including iodine contrast allergy, pregnancy, impaired renal function (eGFR < 45 mL/min), severe arrhythmia, BMI > 40 kg/m2, and inability to cooperate
Recognize risks associated with invasive coronary angiography and use CCTA to minimize unnecessary invasive procedures
Patient & Prescribing Data
Patients with acute chest pain and inconclusive hs-troponin results without prior coronary artery disease
CCTA provides improved diagnostic accuracy for detecting obstructive CAD and helps stratify patients for appropriate management, potentially reducing invasive procedures
Clinical Best Practices
Apply ESC 0-h/1-h hs-troponin algorithms to stratify patients initially
Use CCTA as a non-invasive diagnostic tool in patients with inconclusive hs-troponin results
Administer beta-blockers and nitroglycerin appropriately to optimize image quality during CCTA
Classify and report CCTA findings systematically using CAD-RADS
Unblind CCTA results only when findings have significant prognostic or management implications
Exclude patients with contraindications to CCTA to ensure patient safety
by Murat Arslan, Jeroen Schaap, Bart van Gorsel, Anton Aubanell, Ricardo P. J. Budde, Alexander Hirsch, Martijn W. Smulders, Casper Mihl, Peter Damman, Olga Sliwicka, Jesse Habets, Eric A. Dubois, Admir Dedic
International study of more than 19,000 patients finds substantial differences in radiation exposure from coronary artery disease imaging across modalities, regions, and income levels.
